Speaker Faculty | 13th Alzheimer’s & Parkinson’s Drug Development Summit

2025 Expert Speaker Faculty

alessandro biffi -13th Alzheimer's & Parkinson's Drug Development Summit

Alessandro Biffi

Associate Vice President

Eli Lilly & Co.

andre matta - 13th Alzheimer's & Parkinson's Drug Development Summit

Andre Matta

Executive Director

Ventus Therapeutics

Andrew Kaplan - 13th Alzheimer's & Parkinson's Drug Development Summit

Andrew Kaplan

Principal Scientist

Bristol Myers Squibb

aparna vasanthakuma - 13th Alzheimer's & Parkinson's Drug Development Summitr

Aparna Vasanthakumar

Senior Principal Research Scientist

Abbvie

Ashley Bernardo - 13th Alzheimer's & Parkinson's Drug Development Summit

Ashley Bernardo

Scientific Director

Transpharmation Ltd

Beth Hoffman - 13th Alzheimer's & Parkinson's Drug Development Summit

Beth Hoffman

Chief Executive Officer

Origami Therapeutics, Inc.

Bruce Morimoto - 13th Alzheimer's & Parkinson's Drug Development Summit

Bruce Morimoto

Head, Drug Development

Fuku Biotech

carrie rubel - 13th Alzheimer's & Parkinson's Drug Development Summit

Carrie Rubel

Director - Scientific & Biomarkers

Biogen

chloe whitehouse - 13th Alzheimer's & Parkinson's Drug Development Summit

Chloe Whitehouse

Senior Specialist, 3D Biofabrication

Merck & Co

Christopher Bunker

Chief Business Officer

Alamar Biosciences Inc.

christopher gibbons - 13th Alzheimer's & Parkinson's Drug Development Summit

Christopher Gibbons

Chief Scientific Officer & Co-Founder

CND Life Sciences

daniel klamer - 13th Alzheimer's & Parkinson's Drug Development Summit

Daniel Klamer

Vice President - Business Development & Scientific Strategy

Anavex

Dean Petkanas - 13th Alzheimer's & Parkinson's Drug Development Summit

Dean Petkanas

Co-Founder; Chairman & Chief Executive Officer

KannaLife Sciences Inc

Edmond Teng

Senior Group Medical Director

Genentech

Elena Dale - 13th Alzheimer's & Parkinson's Drug Development Summit

Elena Dale

Executive Director, Neuroscience

Bristol Myers Squibb

Eric Siemers - 13th Alzheimer's & Parkinson's Drug Development Summit

Eric Siemers

Chief Medical Officer

Acumen Pharmaceuticals

Fabian Svara - 13th Alzheimer's & Parkinson's Drug Development Summit

Fabian Svara

Co-founder & Chief Executive Officer

ariadne.ai ag

Fraser Bocell - 13th Alzheimer's & Parkinson's Drug Development Summit

Fraser Bocell

Senior Clinical Outcomes Assessment Scientist

Critical Path Institute (C-Path)

Ginger-Johnson - 13th Alzheimer's & Parkinson's Drug Development Summit

Ginger Johnson

Senior Vice President, Strategy Consulting

Lumanity

Gül Erdemli- 13th Alzheimer's & Parkinson's Drug Development Summit

Gül Erdemli

Global Program Regulatory Director

Novartis AG

ivana rubino - 13th Alzheimer's & Parkinson's Drug Development Summit

Ivana Rubino

Vice President & Head of Global Medical Neuropsychiatry & Alzheimer's disease

Biogen

Jackie Olley -Williams- 13th Alzheimer's & Parkinson's Drug Development Summit

Jackie Olley-Williams

Senior Data Scientist

Eisai Co., Ltd.

Janaky Coomaraswamy -Williams- 13th Alzheimer's & Parkinson's Drug Development Summit

Janaky Coomaraswamy

Director

Takeda Pharmaceutical

Kaare Bjerregaard-Andersen -Williams - 13th Alzheimer's & Parkinson's Drug Development Summit

Kaare Bjerregaard-Andersen

Principal Scientist

H. Lundbeck A/S

Katie Planey - 13th Alzheimer's & Parkinson's Drug Development Summit

Katie Planey

CEO

Acelot, Inc.

Kenneth Gregory Pugh - 13th Alzheimer's & Parkinson's Drug Development Summit

Kenneth Pugh MD MSc

Memory disorders physician

Norton Healthcare

Luis Oliveira - 13th Alzheimer's & Parkinson's Drug Development Summit

Luis Oliveira

Senior Associate Director, Research Programs

Michael J. Fox Foundation

Manuela Polydoro - 13th Alzheimer's & Parkinson's Drug Development Summit

Manuela Polydoro

Head of Translational Medicine

Muna Therapeutics

Maria Maccecchini - 13th Alzheimer's & Parkinson's Drug Development Summit

Maria Maccecchini

Chief Executive Officer

Annovis Bio

Melody Libby - 13th Alzheimer's & Parkinson's Drug Development Summit

Melody Libby

Alzheimer's & Pipeline Patient Advocacy Lead

Biogen

Michael Erkkinen - 13th Alzheimer's & Parkinson's Drug Development Summit

Michael Erkkinen

Instructor in Neurology

Brigham and Women's Hospital

Nadia Eckert - 13th Alzheimer's & Parkinsons Drug Development Summit

Nadia Eckert

Senior Director, R&D

Elixirgen Scientific

Natasha Penner

Senior Director, Head of Clinical Pharmacology

Eisai

neil cashman - 13th Alzheimer's & Parkinson's Drug Development Summit

Neil Cashman

CSO

ProMIS Neurosciences

Pallavi Sachdev - 13th Alzheimer's & Parkinson's Drug Development Summit

Pallavi Sachdev

Executive Director, Translational Medicine

Eisai Co., Ltd.

partick-howson - Atuka - 13th Alzheimer's & Parkinson's Drug Development Summit

Patrick Howson

Chief Innovation Officer

Atuka

paul edison - 13th Alzheimer's & Parkinson's Drug Development Summit

Paul Edison

Professor

Imperial College London

Peter DiBiaso - 13th Alzheimer's & Parkinson's Drug Development Summit

Peter DiBiaso

Patient

The Michael J. Fox Foundation for Parkinson's Research

Ralf Schmid - 13th Alzheimer's & Parkinson's Drug Development Summit

Ralf Schmid

Associate Director- Pre-Clinical Research

Novartis AG

Rebecca Edelmayer - 13th Alzheimer's & Parkinson's Drug Development Summit

Rebecca Edelmayer

Vice President, Scientific Engagement

Alzheimer's Association

Sandi See Tai - 13th Alzheimer's & Parkinson's Drug Development Summit

Sandi See Tai

Chief Development Officer

Lexeo Therapeutics

Sarah Veugelen - 13th Alzheimer's & Parkinsons Drug Development Summit

Sarah Veugelen

Director Neuroscience

Creative BioLabs

Sathya Ganesan - 13th Alzheimer's & Parkinson's Drug Development Summit

Sathya ganesan

Regulatory Science lead

UCB

Sean Pintchovski - 13th Alzheimer's & Parkinson's Drug Development Summit

Sean Pintchovski

Vice President, Biology

AcureX Therapeutics

Shane Hegarty - 13th Alzheimer's & Parkinson's Drug Development Summit

Shane Hegarty

Chief Scientific Officer & Co-Founder

Axonis Therapeutics

shannon leslie - 13th Alzheimer's & Parkinson's Drug Development Summit

Shannon Leslie

Senior Scientist

Johnson & Johnson

Spring Behrouz - 13th Alzheimer's & Parkinson's Drug Development Summit

Spring Behrouz

Chief Executive Officer

Vincere Biosciences

Steven Arnold- 13th Alzheimer's & Parkinson's Drug Development Summit

Steven Arnold

Director - Neurology ,Memory Disorders Unit Normal Pressure Hydrocephalus Program

Cardiovasuclar Genetics

Tammy Dellovade- 13th Alzheimer's & Parkinson's Drug Development Summit

Tammy Dellovade

Senior Research Fellow, Discovery Neuroscience

Abbvie

Tony Bannon - 13th Alzheimer's & Parkinson's Drug Development Summit

Tony Bannon

Senior Director - Scientific, Precision Medicine & Neuroscience

Abbvie

Tricia Thornton-Wells - 13th Alzheimer's & Parkinson's Drug Development Summit

Tricia Thornton-Wells

Senior Director, Compound Development Team Leader

Johnson & Johnson

Urs Langen - 13th Alzheimer's & Parkinson's Drug Development Summit

Urs Langen

Lab Head

Roche

will shrader - 13th Alzheimer's & Parkinson's Drug Development Summit

William Shrader

CSO

AcureX Therapeutics

Xavier Langlois - 13th Alzheimer's & Parkinson's Drug Development Summit

Xavier Langlois

Head of Tau Pathobiology & Research Fellow

Abbvie

FULL EVENT GUIDE

PRE-CONFERENCE DAY